GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
| Website | http://www.gc-tx.com |
| Employees | 44 (35 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
Twitter
+4 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Translational Research, Stem Cell Therapy, Clinical Development, Synthetic Biology, Cell Reprogramming, Life Sciences, Regenerative Medicine, Cellular Therapy, Drug Discovery, Biotechnology, Cell Engineering, Pharmaceutical, Bioprocessing, Precision Medicine, Therapeutic Cells, Advanced Therapy Medicinal Products, Cell Manufacturing, Biopharma |
| Competitors | Amgen, Novartis, Gilead Sciences, AbbVie, Vertex Pharmaceuticals, Genentech, Biogen, Regeneron, Lilly India, Sarepta Therapeutics, Inc. +43 more (view full list) |
Looking for a particular GC Therapeutics employee's phone or email?
Parastoo Khoshakhlagh is the CEO and Co-Founder of GC Therapeutics.
35 people are employed at GC Therapeutics.
GC Therapeutics is based in Cambridge, Massachusetts.